Basit öğe kaydını göster

dc.contributor.authorBaker, Justin T.
dc.contributor.authorOenguer, Dost
dc.contributor.authorPfaff, Danielle L.
dc.contributor.authorHeckers, Stephan
dc.contributor.authorRenshaw, Perry
dc.contributor.authorYuksel, Cagri
dc.contributor.authorMcCarthy, Julie
dc.contributor.authorShinn, Ann
dc.date.accessioned2021-03-06T08:56:28Z
dc.date.available2021-03-06T08:56:28Z
dc.identifier.citationYuksel C., McCarthy J., Shinn A., Pfaff D. L. , Baker J. T. , Heckers S., Renshaw P., Oenguer D., "Gray matter volume in schizophrenia and bipolar disorder with psychotic features", SCHIZOPHRENIA RESEARCH, cilt.138, ss.177-182, 2012
dc.identifier.issn0920-9964
dc.identifier.othervv_1032021
dc.identifier.otherav_e3588d9e-7af3-48f4-942b-18a8923e691d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/149613
dc.identifier.urihttps://doi.org/10.1016/j.schres.2012.03.003
dc.description.abstractThere is growing evidence that schizophrenia (SZ) and bipolar disorder (BD) overlap significantly in risk factors, neurobiological features, clinical presentations, and outcomes. SZ is characterized by well documented gray matter (GM) abnormalities in multiple frontal, temporal and subcortical structures. Recent voxel-based morphometry (VBM) studies and meta-analyses in BD also report GM reductions in overlapping, albeit less widespread, brain regions. Psychosis, a hallmark of SZ, is also experienced by a significant proportion of BD patients and there is evidence that psychotic BD may be characterized by specific clinical and pathophysiological features. However, there are few studies comparing GM between SZ and psychotic BD. In this study we compared GM volumes in a sample of 58 SZ patients, 28 BD patients experiencing psychotic symptoms and 43 healthy controls using whole-brain voxel-based morphometry. SZ patients had GM reductions in multiple frontal and temporal regions compared to healthy controls and in the subgenual cortex compared to psychotic BD patients. GM volume was increased in the right posterior cerebellum in SZ patients compared to controls. However, psychotic BD patients did not show significant GM deficits compared to healthy controls or SZ patients. We conclude that GM abnormality as measured by VBM analysis is less pronounced in psychotic BD compared to SZ. This may be due to disease-specific factors or medications used more commonly in BD. (C) 2012 Elsevier B.V. All rights reserved.
dc.language.isoeng
dc.subjectPsikiyatri
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.titleGray matter volume in schizophrenia and bipolar disorder with psychotic features
dc.typeMakale
dc.relation.journalSCHIZOPHRENIA RESEARCH
dc.contributor.departmentHarvard University , ,
dc.identifier.volume138
dc.identifier.startpage177
dc.identifier.endpage182
dc.contributor.firstauthorID205008


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster